🇺🇸 FDA
Patent

US 7678802

Quinazolines useful as modulators of ion channels

granted A61PA61P1/04A61P19/00

Quick answer

US patent 7678802 (Quinazolines useful as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P1/04, A61P19/00, A61P19/02, A61P21/02